Location History:
- St. Christopher, FR (1996)
- Saint-Christol-les-Ales, FR (1996)
- Saint-Christol-les-Alees, FR (1999)
- Saint-Chistol-les-Ales, FR (2005)
Company Filing History:
3 out of 5,089 
1 out of 223 
1 out of 1 Years Active: 1996-2005
Title: **Gerard Devauchelle: Innovator in Recombinant Technology**
Introduction
Gerard Devauchelle is an accomplished inventor based in Saint-Chistol-les-Ales, France. He has made significant contributions in the field of biotechnology, specifically focusing on the development of tools and methodologies for producing monoclonal antibodies. With a portfolio of 4 patents, his work plays a critical role in advancing therapeutic applications.
Latest Patents
Devauchelle's latest inventions include the "Recombinant baculovirus and use thereof in the production of monoclonal antibodies," which innovatively utilizes recombinant baculovirus as an expression vector for producing immunoglobulins in insect cells. This invention features a first expression cassette that includes a sequence coding for a portion of an immunoglobulin heavy chain, controlled by a specific baculovirus promoter. Additionally, it encompasses a second expression cassette coding for a portion of an immunoglobulin light chain, with its own separate baculovirus promoter. The unique aspect of this invention is the use of different promoters, each operating from distinct loci, allowing for enhanced regulation and efficiency in gene expression.
Career Highlights
Throughout his career, Gerard Devauchelle has worked with notable research institutions such as the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Recherche Agronomique. His roles in these esteemed organizations have facilitated significant advancements in the application of recombinant technology for therapeutic purposes.
Collaborations
Among his esteemed colleagues are Martine Cerutti and Guy Croizier, who have collaborated with Devauchelle in various research projects. Their combined efforts contribute to the innovation and exploration of new methodologies in the field of biotechnology.
Conclusion
Gerard Devauchelle’s contributions to the field of recombinant technology position him as a prominent figure in biotechnology. His innovative patents not only enhance the production of monoclonal antibodies but also pave the way for future advancements in therapeutic applications. Through his research collaborations and dedication to science, Devauchelle continues to make a significant impact on the industry.